In this video, Prof Uwe Zeymer (Klinikum Ludwigshafen, Ludwigshafen, DE) discusses the ARIADNE trial - understanding the current utilization of Angiotensin Receptor-Neprilysin Inhibitor (ARNI) therapy in HFrEF.
Filmed on site at ESC 2019 by Radcliffe Cardiology
This interview is a component of a wider Radcliffe Education programme entitled, 'Review of emerging ARNI data in HFrEF'. Certified accreditation of the full programme is pending following application to the European Board for Accreditation in Cardiology (EBAC). Once accredited the programme will be available on www.radcliffeeducation.com.
This video was partially funded by an unrestricted educational grant from Novartis.